LINC02491

Across TCGA pan-cancer cohorts, LINC02491 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated LINC02491 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher LINC02491 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02491 expression acts as an unfavorable survival marker.

OV, CESC, and TGCT are the cancer types where LINC02491 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	IV	0.028	0.759	.002	36	view →
CESC	OS	Tertile	II,III,IV	0.132	0.829	<.001	36	view →
TGCT	OS	Tertile	III,IV	0.501	1.000	.014	18	view →
KIRC	DFS	Tertile	All	0.236	0.796	.007	18	view →
PRAD	OS	Tertile	All	0.903	0.992	<.001	18	view →
LIHC	DFS	Tertile	All	0.014	0.543	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

LINC02491–OV (OS)

Open the OV breakdown →